ticagrelor(Brilinta)
P2Y12 platelet receptor inhibitor (reversible)
Pronunciation
/taɪˈkæɡrəlɔːr/
International Phonetic Alphabet (IPA). Say it aloud once — you will remember it forever.
At a glance
- Generic name
- ticagrelor
- Brand names
- Brilinta
- Therapeutic class
- P2Y12 platelet receptor inhibitor (reversible)
- Mechanism (summary)
- <!-- AI-DRAFTED: 2026-06-24 -->
Clinical pearls
- Take twice daily, with or without food. Do not miss doses.
- Maintenance aspirin MUST be 81 mg/day (not 325 mg).
- Report bleeding, black stools, or shortness of breath.
- Tablets may be crushed and mixed with water.
- Do not stop without consulting cardiology.
Sources
See how ticagrelor appears in NAPLEX-style questions
PharmDHub Premium includes a full drug card, dosing, boxed warnings, drug-drug interactions, and practice questions built around this drug.